ABCB1 and ovarian cancer: This level of MDR1 expression is somewhat higher than those observed in a cohort of drug-resistant ovarian cancer patients, which were found to be up to 653-fold higher than the SK-OV-3 cell line [35], suggesting that our choice of cell lines provides stringent models for the evaluation of MDR1-mediated drug resistance in ovarian cancer.